Quality Control of Biological Detection Reagents: Key Considerations from Raw Materials to Applications

Real-world context for quality control of biological detection reagents

Biological detection reagents are widely used in fields such as infectious disease screening, tumor marker monitoring, auxiliary diagnosis of genetic diseases, and food safety and environmental monitoring. Because test results often directly affect clinical decisions or public health judgments, the quality stability of the reagents themselves has become a core concern of the industry. Unlike ordinary chemical reagents, biological detection reagents usually contain biologically active components such as antigens, antibodies, enzymes, and nucleic acid probes, and these components are relatively sensitive to temperature, pH, ionic strength, and storage time. Therefore, from upstream raw materials to end use, establishing a systematic approach to quality control is the foundation for ensuring reproducible and traceable test results. Before research and development and market launch, relevant companies generally conduct systematic evaluations of reagent performance indicators in accordance with current regulations and standards, and continuously monitor key parameters during production.

Screening of key raw materials and batch-to-batch consistency

The quality of biological detection reagents depends heavily on key raw materials. Common core raw materials include recombinant antigens, monoclonal or polyclonal antibodies, DNA polymerase, reverse transcriptase, primers, and probes. The purity, activity, affinity, and batch-to-batch variability of raw materials are directly transmitted to the sensitivity and specificity of the finished reagent. The industry generally requires the establishment of a supplier audit system, incoming inspection of key raw materials, and retention of necessary quality documentation. For antibody raw materials, titer, cross-reactivity, and stability are usually considered; for enzyme raw materials, enzyme activity units, purity, and residual nucleic acid levels are considered. To reduce batch-to-batch fluctuations, some companies use reserves of the same raw material batch or conduct mixed-batch validation of multiple raw material batches. It should be emphasized that there is no universally applicable approach to raw material screening; it is more a matter of achieving a balance among performance, cost, and supply stability, and forming internal company control standards through the accumulation of data.

Stability control in the production process

The production of biological detection reagents involves multiple steps such as buffer preparation, labeling, coating, lyophilization, and aliquoting, and fluctuations in any step may affect final performance. For example, the conjugation ratio of enzyme-labeled antibodies, the choice of blocking solution, the lyophilization curve settings, and aliquoting precision are all process parameters that require key control. A common practice is to identify critical quality attributes and critical process parameters during process development and confirm the operating range through process validation. Temperature and humidity, cleanliness, and cross-contamination risks in the production environment also need to be included in management. For liquid reagents, pH and conductivity are common monitoring indicators; for lyophilized reagents, appearance, moisture content, and reconstitution time are generally included in release testing. The core of process stability lies in reducing intra-batch and inter-batch differences rather than pursuing a certain absolute value, so companies usually achieve continuous improvement through trend analysis and statistical process control.

Common dimensions of performance validation

Performance validation of biological detection reagents generally covers dimensions such as sensitivity, specificity, precision, linear range, accuracy, and stability. Sensitivity reflects the reagent's ability to detect low concentrations of the target, while specificity measures its ability to distinguish similar or interfering substances. Precision is usually evaluated through repeatability and intermediate precision tests, while linear range is used to define the concentration interval within which accurate quantification is possible. For qualitative reagents, attention should also be paid to the repeatability of samples near the limit of detection; for quantitative reagents, the fitting method of the calibration curve and the selection of quality control materials are particularly critical. Stability studies include real-time stability, accelerated stability, open-vial stability, and transport stability, among others. It should be noted that reagents with different methodologies and intended uses do not have the same performance requirements, and companies should set validation protocols based on product characteristics and relevant technical guidance principles, and should not simply apply the parameters of other products.

Risk prevention and control in storage, transportation, and use

The active components of biological detection reagents are temperature-sensitive, and temperature control management during storage and transportation directly affects usage performance. Common storage conditions include refrigeration, freezing, and room temperature protected from light, and the specific conditions should be implemented according to the product instructions. During transportation, cold chain breaks, repeated freeze-thaw cycles, or prolonged exposure to high temperatures may cause a decrease in activity. Therefore, companies generally determine acceptable transport temperature ranges and time limits through stability data, and use phase change materials, temperature recorders, or indicator labels in packaging for monitoring. Risks also exist at the point of use; for example, improper sample handling, insufficient reagent equilibration to room temperature, mixing of different lot numbers, and pipette calibration deviations may all introduce errors. To reduce risks at the user end, the instructions should clearly indicate operating procedures, precautions, and storage requirements, and when necessary, quality control materials or standards may be provided to facilitate routine performance verification by laboratories.

Compliance management and document traceabilityIn mainland China, if biological detection reagents are used for in vitro diagnostic purposes, they are generally required to be classified and managed in accordance with medical device regulations. Companies should establish a quality management system appropriate to the product's risk level, covering design and development, procurement, production, inspection, sales, and post-market surveillance. Documentation records are important evidence of the operation of the quality system, including batch production records, inspection records, equipment usage logs, training records, and customer complaints and adverse event reports. Full traceability through batch numbers or serial numbers helps to quickly identify affected batches and take corrective measures when quality issues arise. At the same time, the content of labels and instructions should be truthful and accurate, and must not contain absolute statements or claims of therapeutic efficacy. The continuous improvement of industry standards also prompts biological detection reagent companies to place greater emphasis on compliance baselines and quality culture while pursuing technological innovation.